These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25129269)

  • 1. Intrinsic bleeding risk in patients with uninterrupted oral anticoagulation undergoing cardiac implantable electronic device procedures: a pilot study.
    De Sensi F; Paneni F; Addonisio L; Breschi M; Miracapillo G; Severi S
    Int J Cardiol; 2014 Oct; 176(3):1420-2. PubMed ID: 25129269
    [No Abstract]   [Full Text] [Related]  

  • 2. Bleeding risk of submuscular ICD implantation with continued oral anticoagulation versus heparin bridging therapy.
    Pecha S; Ayikli A; Wilke I; Hakmi S; Yildirim Y; Gosau N; Reichenspurner H; Willems S; Aydin MA
    Heart Vessels; 2018 Apr; 33(4):441-446. PubMed ID: 29030709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oral anticoagulation doesn't increase hemorrhagic risk in patients undergoing a cardiac pacemaker or defibrillator implantation].
    Amara W; Ben Youssef I; Bonny A; Faron M; Monsel F; Sergent J
    Ann Cardiol Angeiol (Paris); 2010 Nov; 59(5):255-9. PubMed ID: 20883977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial.
    Essebag V; Healey JS; Ayala-Paredes F; Kalfon E; Coutu B; Nery P; Verma A; Sapp J; Philippon F; Sandhu RK; Coyle D; Eikelboom J; Wells G; Birnie DH
    Am Heart J; 2016 Mar; 173():102-7. PubMed ID: 26920602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative anticoagulation management in patients on chronic oral anticoagulant therapy undergoing cardiac devices implantation: a meta-analysis.
    Du L; Zhang Y; Wang W; Hou Y
    Pacing Clin Electrophysiol; 2014 Nov; 37(11):1573-86. PubMed ID: 25234639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with novel oral anticoagulants in a real-world cohort of patients undergoing cardiac rhythm device implantations.
    Kosiuk J; Koutalas E; Doering M; Sommer P; Rolf S; Breithardt OA; Nedios S; Dinov B; Hindricks G; Richter S; Bollmann A
    Europace; 2014 Jul; 16(7):1028-32. PubMed ID: 24489073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implanting cardiac rhythm devices during uninterrupted warfarin therapy: a prospective, single center experience.
    Crosato M; Calzolari V; Franceschini Grisolia E; Daniotti A; Baldessin F; Mantovan R; Olivari Z
    J Cardiovasc Med (Hagerstown); 2015 Jul; 16(7):503-6. PubMed ID: 25022924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing anticoagulation in patients receiving implantable cardiac devices.
    Mangrolia N; Nayar V; Pugh PJ
    Future Cardiol; 2012 May; 8(3):393-411. PubMed ID: 26203472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing periprocedural anticoagulation therapy in patients undergoing device implantation: survey in Germany, Austria and Switzerland.
    Blaschke F; Lacour P; Wutzler A; Huemer M; Parwani AS; Attanasio P; Pieske B; Boldt L-; Haverkamp W
    Acta Cardiol; 2016; 71(5):549-556. PubMed ID: 27695012
    [No Abstract]   [Full Text] [Related]  

  • 10. The safety and efficacy of antithrombotic therapy in patients undergoing cardiac rhythm device implantation: a meta-analysis.
    Yang X; Wang Z; Zhang Y; Yin X; Hou Y
    Europace; 2015 Jul; 17(7):1076-84. PubMed ID: 25713013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral anticoagulation and implantation of cardiac rhythm management devices: is heparin a bridge too far?
    Kakouros N
    Hellenic J Cardiol; 2013; 54(2):150-1. PubMed ID: 23557618
    [No Abstract]   [Full Text] [Related]  

  • 12. Meta-analysis of safety and efficacy of uninterrupted warfarin compared to heparin-based bridging therapy during implantation of cardiac rhythm devices.
    Ghanbari H; Phard WS; Al-Ameri H; Latchamsetty R; Jongnarngsin K; Crawford T; Good E; Chugh A; Oral H; Bogun F; Morady F; Pelosi F
    Am J Cardiol; 2012 Nov; 110(10):1482-8. PubMed ID: 22906894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between warfarin, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of hematoma formation after device implantation.
    Thal S; Moukabary T; Boyella R; Shanmugasundaram M; Pierce MK; Thai H; Goldman S
    Pacing Clin Electrophysiol; 2010 Apr; 33(4):385-8. PubMed ID: 20059711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation bridging around device surgery: compliance with guidelines.
    Perrin MJ; Vezi BZ; Ha AC; Keren A; Nery PB; Birnie DH
    Pacing Clin Electrophysiol; 2012 Dec; 35(12):1480-6. PubMed ID: 22978770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantation of cardiac rhythm devices during concomitant anticoagulation or antiplatelet therapy.
    Ramirez A; Wall TS; Schmidt M; Selzman K; Daccarett M
    Expert Rev Cardiovasc Ther; 2011 May; 9(5):609-14. PubMed ID: 21615324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin.
    Tischenko A; Gula LJ; Yee R; Klein GJ; Skanes AC; Krahn AD
    Am Heart J; 2009 Aug; 158(2):252-6. PubMed ID: 19619702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No increased bleeding events with continuation of oral anticoagulation therapy for patients undergoing cardiac device procedure.
    Li HK; Chen FC; Rea RF; Asirvatham SJ; Powell BD; Friedman PA; Shen WK; Brady PA; Bradley DJ; Lee HC; Hodge DO; Slusser JP; Hayes DL; Cha YM
    Pacing Clin Electrophysiol; 2011 Jul; 34(7):868-74. PubMed ID: 21410724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing novel oral anticoagulants in patients with atrial fibrillation undergoing device surgery: Canadian survey.
    Nascimento T; Birnie DH; Healey JS; Verma A; Joza J; Bernier ML; Essebag V
    Can J Cardiol; 2014 Feb; 30(2):231-6. PubMed ID: 24461924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal strategies for the management of antiplatelet and anticoagulation medications prior to cardiac device implantation.
    Tompkins C; Henrikson CA
    Cardiol J; 2011; 18(1):103-9. PubMed ID: 21305497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current strategies to minimize postoperative hematoma formation in patients undergoing cardiac implantable electronic device implantation: A review.
    Mehta NK; Doerr K; Skipper A; Rojas-Pena E; Dixon S; Haines DE
    Heart Rhythm; 2021 Apr; 18(4):641-650. PubMed ID: 33242669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.